Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome.

Martínez C, González-Castro A, Vicario M, Santos J.

Gut Liver. 2012 Jul;6(3):305-15. doi: 10.5009/gnl.2012.6.3.305. Epub 2012 Jul 12.

2.

Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.

Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M.

Gut. 2013 Aug;62(8):1160-8. doi: 10.1136/gutjnl-2012-302093. Epub 2012 May 25.

PMID:
22637702
3.

Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?

Piche T.

Neurogastroenterol Motil. 2014 Mar;26(3):296-302. doi: 10.1111/nmo.12315. Review.

4.

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Ohman L, Simrén M.

Nat Rev Gastroenterol Hepatol. 2010 Mar;7(3):163-73. doi: 10.1038/nrgastro.2010.4. Epub 2010 Jan 26. Review.

PMID:
20101257
5.

Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.

Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.

J Clin Gastroenterol. 2012 Oct;46 Suppl:S52-5. doi: 10.1097/MCG.0b013e318264e918.

PMID:
22955358
6.

The immune system in irritable bowel syndrome.

Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V.

J Neurogastroenterol Motil. 2011 Oct;17(4):349-59. doi: 10.5056/jnm.2011.17.4.349. Epub 2011 Oct 31.

7.

Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in Irritable Bowel Syndrome.

González-Castro AM, Martínez C, Salvo-Romero E, Fortea M, Pardo-Camacho C, Pérez-Berezo T, Alonso-Cotoner C, Santos J, Vicario M.

J Gastroenterol Hepatol. 2016 Apr 18. doi: 10.1111/jgh.13417. [Epub ahead of print] Review.

PMID:
27087165
8.

Mucosal barrier defects in irritable bowel syndrome. Who left the door open?

Barbara G.

Am J Gastroenterol. 2006 Jun;101(6):1295-8.

PMID:
16771952
9.

Intestinal barrier function in health and gastrointestinal disease.

Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN.

Neurogastroenterol Motil. 2012 Jun;24(6):503-12. doi: 10.1111/j.1365-2982.2012.01921.x. Review. Erratum in: Neurogastroenterol Motil. 2012 Oct;24(10):976. Van Meerveld, B G [corrected to Greenwood-Van Meerveld, B].

10.

Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.

Vicario M, Guilarte M, Alonso C, Yang P, Martínez C, Ramos L, Lobo B, González A, Guilà M, Pigrau M, Saperas E, Azpiroz F, Santos J.

Brain Behav Immun. 2010 Oct;24(7):1166-75. doi: 10.1016/j.bbi.2010.06.002. Epub 2010 Jun 25.

PMID:
20600818
11.

Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.

Hyland NP, Quigley EM, Brint E.

World J Gastroenterol. 2014 Jul 21;20(27):8859-66. doi: 10.3748/wjg.v20.i27.8859. Review.

12.

Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.

Ringel Y, Maharshak N.

Am J Physiol Gastrointest Liver Physiol. 2013 Oct 15;305(8):G529-41. doi: 10.1152/ajpgi.00207.2012. Epub 2013 Jul 25. Review.

13.

The putative role of the intestinal microbiota in the irritable bowel syndrome.

Collins SM, Denou E, Verdu EF, Bercik P.

Dig Liver Dis. 2009 Dec;41(12):850-3. doi: 10.1016/j.dld.2009.07.023. Epub 2009 Sep 8. Review.

PMID:
19740713
14.

Gut inflammation in chronic fatigue syndrome.

Lakhan SE, Kirchgessner A.

Nutr Metab (Lond). 2010 Oct 12;7:79. doi: 10.1186/1743-7075-7-79.

15.

[Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome].

Piche T.

Gastroenterol Clin Biol. 2009 Feb;33 Suppl 1:S40-7. doi: 10.1016/S0399-8320(09)71524-6. French.

16.

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.

Camilleri M, Lasch K, Zhou W.

Am J Physiol Gastrointest Liver Physiol. 2012 Oct;303(7):G775-85. doi: 10.1152/ajpgi.00155.2012. Epub 2012 Jul 26. Review.

17.

[The pathophysiology of irritable bowel syndrome: inflammation and motor disorder].

Park H.

Korean J Gastroenterol. 2006 Feb;47(2):101-10. Review. Korean.

18.

Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?

Xu XJ, Liu L, Yao SK.

J Zhejiang Univ Sci B. 2016 Jan;17(1):1-9. doi: 10.1631/jzus.B1500181.

19.

[Irritable bowel syndrome: from the gut to the brain-gut].

Ducrotté P.

Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):703-12. doi: 10.1016/j.gcb.2009.07.006. Epub 2009 Aug 13. French.

20.

Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.

Wilcz-Villega EM, McClean S, O'Sullivan MA.

Am J Gastroenterol. 2013 Jul;108(7):1140-51. doi: 10.1038/ajg.2013.92. Epub 2013 Apr 16.

PMID:
23588236
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk